Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT): Price and Financial Metrics

Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT)

Today's Latest Price: $5.97 USD

0.04 (0.67%)

Updated May 29 4:00pm

Add OSMT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

OSMT Stock Summary

  • OSMT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.3 -- higher than merely 5.58% of US-listed equities with positive expected earnings growth.
  • OSMT's went public 1.62 years ago, making it older than merely 2.46% of listed US stocks we're tracking.
  • Of note is the ratio of Osmotica Pharmaceuticals plc's sales and general administrative expense to its total operating expenses; just 11.61% of US stocks have a lower such ratio.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Osmotica Pharmaceuticals plc are MNK, CPA, TIPT, NES, and RFP.
  • To dig deeper into the stock's financial statements, go to OSMT's page on browse-edgar?action=getcompany&CIK=0001739426.
OSMT Daily Price Range
OSMT 52-Week Price Range

OSMT Stock Price Chart More Charts

OSMT Price/Volume Stats

Current price $5.97 52-week high $7.97
Prev. close $5.93 52-week low $2.30
Day low $5.75 Volume 321,364
Day high $6.37 Avg. volume 304,358
50-day MA $4.04 Dividend yield N/A
200-day MA $4.75 Market Cap 307.58M

Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT) Company Bio

Osmotica Pharmaceuticals Plc is a holding company engages in the development and commercialization of specialty products that target markets with underserved patient populations. It offers the M-72, Lorzone which is the chlorzoxazone scored tablets and ConZip which is tramadol hydrochloride extended-release capsules in specialty neurology; and OB Complete, which is the family of prescription prenatal dietary supplements, and Divigel in women's health. The company was founded on July 13, 2017 and is headquartered in Bridgewater, NJ.

OSMT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Osmotica Pharmaceuticals plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Osmotica Pharmaceuticals plc ranked in the 13th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 86.17%. In terms of the factors that were most noteworthy in this DCF analysis for OSMT, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 56. Notably, its equity weight is greater than merely 15.56% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The company's compound free cash flow growth rate over the past 1.61 years comes in at -0.2%; that's greater than only 9.18% of US stocks we're applying DCF forecasting to.
  • Osmotica Pharmaceuticals plc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -15.47. This coverage rate is greater than that of only 5.61% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OSMT, try IDXX, ICUI, MOH, QGEN, and A.

OSMT Latest News Stream

Event/TimeNews Detail
Loading, please wait...

OSMT Latest Social Stream

Loading social stream, please wait...

View Full OSMT Social Stream

Latest OSMT News From Around the Web

Below are the latest news stories about Osmotica Pharmaceuticals plc that investors may wish to consider to help them evaluate OSMT as an investment opportunity.

Osmotica Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("Osmotica" or the "Company"), a fully integrated biopharmaceutical company, today announced results of the Company's Annual General Meeting.

Yahoo | May 27, 2020

Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual Healthcare Conference

BRIDGEWATER, N.J., May 26, 2020 -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that.

Yahoo | May 26, 2020

Here's What Analysts Are Forecasting For Osmotica Pharmaceuticals plc (NASDAQ:OSMT) After Its First-Quarter Results

A week ago, Osmotica Pharmaceuticals plc (NASDAQ:OSMT) came out with a strong set of quarterly numbers that could...

Yahoo | May 15, 2020

3 Biotech Stocks Under $4 That Could Surge Over 50%

It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the green and the red. Yet, since its March 16 low, the S&P 500 has come a long way, rising nearly 18%. Wall Street pros remind investors that one area of the market has performed significantly better than the S&P 500: the biotech sector. As a result, names inhabiting this space have found themselves under the Street’s microscope.Having said that, there is something to consider when making these investment decisions. Biotech stocks are especially volatile due to the characteristics of the industry itself. For these companies, there are only a few key indicators like study results or regulatory approvals to determine whether or not sustainable...

Yahoo | May 14, 2020

Osmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

BRIDGEWATER, N.J., May 13, 2020 -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that.

Yahoo | May 13, 2020

Read More 'OSMT' Stories Here

OSMT Price Returns

1-mo 59.63%
3-mo 6.42%
6-mo -12.46%
1-year 148.75%
3-year N/A
5-year N/A
YTD -14.59%
2019 -9.81%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching OSMT

Want to see what other sources are saying about Osmotica Pharmaceuticals plc's financials and stock price? Try the links below:

Osmotica Pharmaceuticals plc (OSMT) Stock Price | Nasdaq
Osmotica Pharmaceuticals plc (OSMT) Stock Quote, History and News - Yahoo Finance
Osmotica Pharmaceuticals plc (OSMT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1011 seconds.